Trial Profile
Missed Dose Effect of Irbesartan in Hypertensive Patients and Cardiovascular Risk Profile Monitoring Under Irbesartan Treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Irbesartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Sanofi
- 04 Mar 2008 Status changed from in progress to completed.
- 15 Sep 2006 New trial record.